Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.

Revenue
+1.42%
EPS
+17.9%
Free cash flow
+29.0%
Total debt
−3.65%

Quarter to September 2026, against a year earlier

425.62 6.38 −1.48%
Market cap
$93.3B
P/E
18.2×
Fwd P/E
19.0×
Dividend yield
1.61%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
16.58 17.19 12.45 13.96

+8 more quarters

P/S ratio
0.42 0.42 0.32 0.39
P/FCF ratio
12.93 13.34 9.98 24.74
P/Operating CF
66.47 43.87 14.85 934.80
P/B ratio
1.88 1.86 1.46 1.78
EV/Sales
0.38 0.39 0.29 0.37
EV/EBITDA
8.40 8.79 6.38 7.69
EV/FCF
11.84 12.32 9.05 23.41
Current Ratio
1.47 1.52 1.48 1.54
Net Debt/EBITDA
(2.82) (2.43) (1.98) (4.27)
Debt/Equity
0.69 0.69 0.71 0.72
Earnings Yield
6.03% 5.82% 8.03% 7.17%
Free Cash Flow Yield
7.73% 7.49% 10.02% 4.04%
Free Cash Flow per Share
4.62 7.49 18.64 (0.93)
Book value per Share
206.81 207.47 200.37 196.54
Free Cash Flow
1,000.00 1,626.00 4,097.00 (209.00)
EV/EBIT
10.02 10.61 7.65 9.16
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026